Page 66 - Initiated Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Initiated coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Initiated Coverage Today - Breaking & Trending Today

Navidea Biopharmaceuticals (NYSE:NAVB) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB stock opened at $0.04 on Monday. The stock’s fifty day moving average is $0.04 and its 200-day […] ....

Therapeutic Development Programs , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals , Free Report , Get Free Report , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

StockNews.com Initiates Coverage on Birks Group (NYSEAMERICAN:BGI)

StockNews.com began coverage on shares of Birks Group (NYSEAMERICAN:BGI – Free Report) in a research note released on Friday. The brokerage issued a sell rating on the stock. Birks Group Stock Performance NYSEAMERICAN BGI opened at $2.70 on Friday. Birks Group has a 52 week low of $2.40 and a 52 week high of $10.02. […] ....

United States , Hedge Funds Weigh In On Birks Group , Birks Group Inc , Exchange Commission , Birks Group , Ingalls Snyder , Birks Group Stock Performance , News Ratings For Birks Group Daily , Free Report , Get Free Report , Group Inc , Birks Group Daily , Nyseamerican Bgi , Retail Wholesale , Initiated Coverage , Stocknews Com ,

CymaBay Therapeutics (NASDAQ:CBAY) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of CymaBay Therapeutics (NASDAQ:CBAY – Free Report) in a report published on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the company. William Blair cut CymaBay Therapeutics from an outperform rating to a market perform […] ....

Raymond James , Janet Dorling , William Blair , Cantor Fitzgerald , Emerald Advisers , Securities Exchange Commission , Raymond James Financial Services Advisors Inc , Strategic Blueprint , Cymabay Therapeutics Inc , Raymond James Associates , Sg Americas Securities , Cymabay Therapeutics , Free Report , Lifesci Capital , Bay Therapeutics , Get Free Report , Director Janet Dorling , Exchange Commission , James Financial Services Advisors , Cymabay Therapeutics Daily , Nasdaq Cbay , Initiated Coverage , Stocknews Com ,

Morgan Stanley Initiates Coverage on Dyne Therapeutics (NASDAQ:DYN)

Morgan Stanley started coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a report released on Tuesday, Briefing.com reports. The firm set an “overweight” rating and a $40.00 price target on the stock. Morgan Stanley’s price target indicates a potential upside of 57.11% from the company’s previous close. A number of other […] ....

United States , Stifel Nicolaus , Joshuat Brumm , Raymond James , Wildon Farwell , Zurcher Kantonalbank Zurich Cantonalbank , Raymond James Associates , York Mellon Corp , Dyne Therapeutics Inc , Morgan Stanley , Securities Exchange Commission , Allspring Global Investments Holdings , Td Asset Management Inc , Dyne Therapeutics , Get Free Report , Exchange Commission , New York Mellon Corp , Kantonalbank Zurich Cantonalbank , Management Inc , Global Investments Holdings , Dyne Therapeutics Daily , Nasdaq Dyn , Initiated Coverage ,

Vista Outdoor (NYSE:VSTO) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Vista Outdoor (NYSE:VSTO – Free Report) in a report issued on Monday. The brokerage issued a buy rating on the stock. Other equities analysts have also issued reports about the stock. Roth Capital upgraded shares of Vista Outdoor from a neutral rating to a buy rating in a research […] ....

United States , Roth Mkm , Vista Outdoor Company Profile , Fifth Third Bancorp , Board Of Administration Florida Retirement System , Third Bancorp , Summerhaven Investment Management , Vista Outdoor Inc , Vista Outdoor , Free Report , Monness Crespi , Get Free Report , Haven Investment Management , Florida Retirement System , State Retirement System , Outdoor Inc , Sporting Products , Vista Outdoor Daily , Nyse Vsto , Consumer Discretionary , Initiated Coverage , Stocknews Com ,